Copyright
©The Author(s) 2021.
World J Transplant. Oct 18, 2021; 11(10): 432-442
Published online Oct 18, 2021. doi: 10.5500/wjt.v11.i10.432
Published online Oct 18, 2021. doi: 10.5500/wjt.v11.i10.432
Organ | Year | Number of studies | Incidence (%) | 95%CI | I2 (%) |
Liver | Year 1 | 7 | 12.3 | 5.6-24.8 | 89.3 |
Liver | Years 2-3 | 16 | 18.9 | 14.2-24.7 | 94.4 |
Liver | Years 5+ | 5 | 9.0 | 2.9-24.5 | 95.0 |
Kidney | Year 1 | 108 | 12.2 | 10.5-14.1 | 95.3 |
Kidney | Years 2-3 | 73 | 17.3 | 15.1-19.7 | 98.2 |
Kidney | Years 5+ | 71 | 16.3 | 13.9-19 | 93.2 |
Heart | Year 1 | 3 | 29.3 | 9.5-62 | 84.9 |
Heart | Years 2-3 | 10 | 22.4 | 17.1-28.8 | 93.6 |
Heart | Years 5+ | 2 | 17.7 | 14.1-22 | 0.0 |
Lung | Year 1 | 3 | 6.4 | 0.9-34 | 92.8 |
Lung | Years 2-3 | 5 | 18.8 | 8.6-36.3 | 96.8 |
Lung | Years 5+ | 0 | N/A | N/A |
- Citation: Kotha S, Lawendy B, Asim S, Gomes C, Yu J, Orchanian-Cheff A, Tomlinson G, Bhat M. Impact of immunosuppression on incidence of post-transplant diabetes mellitus in solid organ transplant recipients: Systematic review and meta-analysis. World J Transplant 2021; 11(10): 432-442
- URL: https://www.wjgnet.com/2220-3230/full/v11/i10/432.htm
- DOI: https://dx.doi.org/10.5500/wjt.v11.i10.432